Your browser doesn't support javascript.
loading
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer.
Spetsieris, Nicholas; Boukovala, Myrto; Alafis, Ioannis; Davis, John; Zurita, Amado; Wang, Xuemei; Tu, Shi-Ming; Chapin, Brian F; Aparicio, Ana; Corn, Paul; Wang, Jennifer; Subudhi, Sumit K; Araujo, John; Papadopoulos, John; Pruitt, Lisa; Weldon, Justin A; Logothetis, Christopher J; Efstathiou, Eleni.
Afiliação
  • Spetsieris N; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: nicholasspetsieris@gmail.com.
  • Boukovala M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alafis I; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Davis J; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zurita A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tu SM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chapin BF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Aparicio A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Corn P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Subudhi SK; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Araujo J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Papadopoulos J; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pruitt L; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Weldon JA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Efstathiou E; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: eefstathiou@healthpronoia.com.
Eur J Cancer ; 157: 259-267, 2021 11.
Article em En | MEDLINE | ID: mdl-34536949

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata / Calicreínas / Protocolos de Quimioterapia Combinada Antineoplásica / Antígeno Prostático Específico / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata / Calicreínas / Protocolos de Quimioterapia Combinada Antineoplásica / Antígeno Prostático Específico / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido